Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC early clinical trials group
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (8) , 1064-1067
- https://doi.org/10.1016/0959-8049(94)90457-x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Taxotere toxicity — Protective effects of premedicationEuropean Journal Of Cancer, 1993
- Coping with toxicities of docetaxel (TaxotereTM)Annals of Oncology, 1993
- Phase I Trial of Taxotere: Five-Day ScheduleJNCI Journal of the National Cancer Institute, 1992
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991